glp-1 and dementia Agonists GLP-1 Dementia Risk: Hype or

Source: Anglia Ruskin University A new study has found comprehensive evidence that weight-loss GLP-1 receptor agonists such as semaglutide are effective in tackling the biological drivers of Alzheimers disease

Federici, Giorgio (2003)

Prescription and Treatment Planning If appropriate, the clinician designs a plan that includes dosing, administration method, and how the peptides integrate with your overall care strategy

doi: 10.1038/nm.3579 51 BankirLBoubyNBlondeauBCrambertG

They function similarly to a natural hormone produced by your body called GLP-1, short for glucagon-like peptide-1, which regulates blood sugar and hunger signals

In contrast, and consistent with data from mouse ventricular CMs, we observed that GLP-1(2836) failed to protect hESC-CMs from cytotoxicity under conditions of oxidative stress (Supplemental Figure 4C)